Developing a GNN-based AI model to predict mitochondrial toxicity using the bagging method.

Journal: The Journal of toxicological sciences
Published Date:

Abstract

Mitochondrial toxicity has been implicated in the development of various toxicities, including hepatotoxicity. Therefore, mitochondrial toxicity has become a major screening factor in the early discovery phase of drug development. Several models have been developed to predict mitochondrial toxicity based on chemical structures. However, they only provide a binary classification of positive or negative results and do not provide the substructures that contribute to a positive decision. Therefore, we developed an artificial intelligence (AI) model to predict mitochondrial toxicity and visualize structural alerts. To construct the model, we used the open-source software library kMoL, which employs a graph neural network approach that allows learning from chemical structure data. We also utilized the integrated gradient method, which enables the visualization of substructures that contribute to positive results. The dataset used to construct the AI model exhibited a significant imbalance, with significantly more negative than positive data. To address this, we employed the bagging method, which resulted in a model with high predictive performance, as evidenced by an F1 score of 0.839. This model can also be used to visualize substructures that contribute to mitochondrial toxicity using the integrated gradient method. Our AI model predicts mitochondrial toxicity based on chemical structures and may contribute to screening mitochondrial toxicity in the early stages of drug discovery.

Authors

  • Yoshinobu Igarashi
    Toxicogenomics Informatics Project, National Institutes of Biomedical Innovation, Health and Nutrition.
  • Ryosuke Kojima
    Department of Biomedical Data Intelligence, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Kyoto, Japan.
  • Shigeyuki Matsumoto
    Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Hiroaki Iwata
    Division of School of Health Science, Department of Biological Regulation, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan.
  • Yasushi Okuno
    Graduate School of Medicine, Kyoto University, Shogoin-kawaharacho, city/>Sakyo-ku Kyoto, 606-8507, Japan.
  • Hiroshi Yamada
    Toxicogenomics Informatics Project, National Institute of Biomedical Innovation, Health and Nutrition.